Track West Pharmaceutical Services, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

West Pharmaceutical Services, Inc. WST Open West Pharmaceutical Services, Inc. in new tab

254.80 USD
P/E
37.58
EPS
6.78
Yield
0.34%
Safety Score
100
P/B
5.78
ROE
16.86
Beta
1.18
Target Price
316.69 USD
West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc.

🧾 Earnings Recap – Q3 2025

West's Q3 2025 results exceeded expectations with revenues up 5% to $805 million and adjusted EPS rising 6% to $1.96, prompting an increase in FY 2025 guidance.

  • Proprietary Products segment delivered $648 million in revenues, a 5.1% organic increase, driven by strong HVP components related to GLP-1 sales.
  • Adjusted operating margins improved to 21.1%, underscoring operational efficiency.
  • The company has 375 ongoing Annex 1 upgrade projects, boosting growth expectations from 150 to 200 basis points in 2025.
  • Contract Manufacturing segment revenues grew 4.9% organically, benefiting from consolidation efforts in Arizona.
  • Leadership transitions, including a new CFO and CTO, are strategically positioned to enhance innovation and operational growth.
📅
Loading chart...
Key Metrics
Earnings dateApril 23, 2026
P/E37.58
EPS6.78
Book Value44.11
Price to Book5.78
Debt/Equity10.27
% Insiders0.623%
Growth
Revenue Growth0.08%
Earnings Growth0.02%
Estimates
Forward P/E28.78
Forward EPS8.85
Target Mean Price316.69
Dividend
Dividend Yield0.34%
Annual dividends0.86 USD
Ex-Div. DateApril 29, 2026
Payout12.40%
5y avg Yield0.23%

DCF Valuation

Tweak assumptions to recompute fair value for West Pharmaceutical Services, Inc. (WST)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

West Pharmaceutical Services, Inc. Logo West Pharmaceutical Services, Inc. Analysis (WST)

United States Health Care Official Website Stock

Is West Pharmaceutical Services, Inc. a good investment? West Pharmaceutical Services, Inc. (WST) is currently trading at 254.80 USD. Market analysts have a consensus price target of 316.69 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 37.58. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: West Pharmaceutical Services, Inc. is expected to release its next earnings report on April 23, 2026. The market consensus estimate for Forward EPS is 8.85.

For income investors, West Pharmaceutical Services, Inc. pays a dividend yield of 0.34%. With a payout ratio of 12%, the dividend appears sustainable.

Investor FAQ

Does West Pharmaceutical Services, Inc. pay a dividend?

Yes, it pays an annual dividend of 0.86 USD (0.34% yield).

What asset class is West Pharmaceutical Services, Inc.?

West Pharmaceutical Services, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be April 23, 2026. The company currently has a trailing EPS of 6.78.

Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Exchange Ticker
NYQ (United States) WST
GER (Germany) WPS.DE
FRA (Germany) WPS.F
Dividend Yield

0.34% (5y avg: 0.23%)

Annual Dividends

0.86 USD

Next ex. div date

April 29, 2026

Payout Ratio

12.40%

Historical Dividends
Year Total Dividends
2027 0.23 USD
2026 0.89 USD
2025 0.85 USD
2024 0.81 USD
2023 0.77 USD
2022 0.73 USD
2021 0.69 USD
2020 0.65 USD
2019 0.61 USD
2018 0.57 USD
2017 0.53 USD
2016 0.49 USD
2015 0.45 USD
2014 0.41 USD
2013 0.67 USD
2012 0.73 USD
2011 0.69 USD
2010 0.65 USD
2009 0.61 USD
2008 0.57 USD
2007 0.53 USD
2006 0.49 USD
2005 0.45 USD
2004 0.74 USD
2003 0.81 USD
2002 0.77 USD
2001 0.73 USD
2000 0.69 USD
1999 0.65 USD
1998 0.61 USD
1997 0.57 USD
1996 0.53 USD
1995 0.49 USD
1994 0.45 USD
1993 0.41 USD
1992 0.40 USD
1991 0.40 USD
1990 0.40 USD
1989 0.31 USD
1988 0.29 USD
1987 0.40 USD

Yearly aggregated dividends

Dividends

West Pharmaceutical Services, Inc.
May 06, 2026 Upcoming
Dividend
0.22 USD
West Pharmaceutical Services, Inc.
Feb 04, 2026 Paid
Dividend
0.22 USD
West Pharmaceutical Services, Inc.
Nov 19, 2025 Paid
Dividend
0.22 USD
West Pharmaceutical Services, Inc.
Aug 06, 2025 Paid
Dividend
0.21 USD
West Pharmaceutical Services, Inc.
May 07, 2025 Paid
Dividend
0.21 USD

Historical Split Corporate Actions

Split Date Split Ratio to 1
Sept. 29, 2004 2.000000
Sept. 27, 2013 2.000000
Sept. 30, 2004 2.000000
June 2, 1987 2.000000
May 6, 1982 2.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion